Shionogi’s cefiderocol shows improved outcomes with early use in treating gram-negative infections:…
PROVE study reveals significantly improved outcomes with early use of cefiderocol in treating serious gram-negative infections,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.